Baumgold J
Eur J Pharmacol. 1986 Jul 15;126(1-2):151-4. doi: 10.1016/0014-2999(86)90752-1.
The calcium channel antagonist verapamil inhibited [3H]N-methyl scopolamine ([3H]NMS ) binding to muscarinic receptors from both rat brain cortex, an area rich in M1 receptors, and from pons-medulla, an area rich in M2 receptors. Verapamil reduced the dissociation kinetics of [3H]NMS binding in cortical receptors but had no detectable effects on the dissociation kinetics of receptors from the pons-medulla. These data suggest that receptors from the cortex have an allosteric site which regulates the binding kinetics, whereas receptors from the pons-medulla lack this site.
钙通道拮抗剂维拉帕米抑制了[3H]N-甲基东莨菪碱([3H]NMS)与大鼠大脑皮层(富含M1受体的区域)以及脑桥-延髓(富含M2受体的区域)的毒蕈碱受体的结合。维拉帕米降低了皮层受体中[3H]NMS结合的解离动力学,但对脑桥-延髓受体的解离动力学没有可检测到的影响。这些数据表明,皮层的受体具有一个调节结合动力学的变构位点,而脑桥-延髓的受体缺乏该位点。